Lyu Xueman, Wang Ling, Lu Jia, Zhang Hong, Wang Lina
Department of Ophthalmology, China‑Japan Union Hospital of Jilin University, Changchun, Jilin 130033, P.R. China.
Oncol Rep. 2022 Aug;48(2). doi: 10.3892/or.2022.8347. Epub 2022 Jun 15.
Following the publication of the above paper, the authors submitted a request to the Editorial Office to retract the article on account of the fact that the ethical approval for the tumor xenograft experiments performed in mice, as shown in Fig. 7, had not been obtained from their hospital; consequently, all authors were in agreement that the article should be retracted to ensure the integrity of the scholarly record. Independently of this request, it was also drawn to the Editor's attention by a concerned reader that data in several of the figures were strikingly similar to data appearing in different form in other articles by different authors. Owing to the fact that there were contentious data in the above article that had already been published prior to its submission to , and after assessing the authors' request, the Editor concurs that this paper should be retracted from the Journal. The Editor apologizes to the readership for any inconvenience caused. [Oncology Reports 41: 3137-3147, 2019; DOI: 10.3892/or.2019.7061].
上述论文发表后,作者向编辑部提出撤回该文章的请求,原因是图7所示的在小鼠身上进行的肿瘤异种移植实验未获得其所在医院的伦理批准;因此,所有作者一致认为该文章应被撤回,以确保学术记录的完整性。独立于这一请求之外,一位关注此事的读者也提醒编辑注意,该文章中几幅图的数据与其他不同作者的文章中以不同形式出现的数据惊人地相似。由于上述文章在提交给本刊之前就已经存在有争议的数据,并且在评估了作者的请求后,编辑同意应从本刊撤回该论文。编辑就由此造成的不便向读者致歉。[《肿瘤学报道》41: 3137 - 3147, 2019;DOI: 10.3892/or.2019.7061]